Condensed Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating Expenses:
Research and development	$ 3,634,287	$ 4,008,896
General and administrative	1,836,782	1,942,763
Total Operating Expenses	5,471,069	5,951,659
Loss From Operations	(5,471,069)	(5,951,659)
Other Income:
Interest expense	(3,681)
Interest income	23,840	19,275
Net Loss	$ (5,450,910)	$ (5,932,384)
Net Loss Per Share
- Basic and Diluted	$ (0.31)	$ (0.50)
Weighted Average Number of Common Shares Outstanding
- Basic and Diluted	17,308,804	11,919,973